Clinical response to Infliximab is associated with a substantial increase in quality of life.

De Vos, MM;D'Haens, G.;Van Gossum, A;Belaiche, J;Rutgeerts, Paul;et.al.
(2000)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 180.82 KB

Details

Authors
  • De Vos, MM
    Author
  • D'Haens, G.
    Author
  • Van Gossum, A
    Author
  • Belaiche, J
    Author
  • Fiasse, RenéUCLouvain
    Author
  • Rutgeerts, PaulUCLouvain
    Author
Show more
Affiliations

Citations

De Vos, M., D’Haens, G., Van Gossum, A., Belaiche, J., Pelckmans, P., Fiasse, R., Naegels, S., Kerschen, A., & Rutgeerts, P. (2000). Clinical response to Infliximab is associated with a substantial increase in quality of life. Gastroenterology, 118(4), A1338-A1338. https://doi.org/10.1016/S0016-5085(00)81218-4 (Original work published 2000)